1. Home
  2. HBCP vs PRTC Comparison

HBCP vs PRTC Comparison

Compare HBCP & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Bancorp Inc.

HBCP

Home Bancorp Inc.

HOLD

Current Price

$63.14

Market Cap

495.8M

Sector

Finance

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$18.15

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBCP
PRTC
Founded
1908
2015
Country
United States
United States
Employees
481
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
495.8M
464.3M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
HBCP
PRTC
Price
$63.14
$18.15
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$63.50
N/A
AVG Volume (30 Days)
23.0K
2.9K
Earning Date
01-26-2026
08-28-2025
Dividend Yield
1.96%
N/A
EPS Growth
24.56
N/A
EPS
5.62
0.20
Revenue
$145,087,000.00
$6,391,000.00
Revenue This Year
$2.60
N/A
Revenue Next Year
$3.27
N/A
P/E Ratio
$11.28
$8.57
Revenue Growth
11.42
1265.60
52 Week Low
$39.59
$13.30
52 Week High
$63.67
$20.00

Technical Indicators

Market Signals
Indicator
HBCP
PRTC
Relative Strength Index (RSI) 65.98 52.17
Support Level $59.54 $17.31
Resistance Level $62.02 $18.82
Average True Range (ATR) 1.45 0.66
MACD 0.31 0.02
Stochastic Oscillator 82.79 34.47

Price Performance

Historical Comparison
HBCP
PRTC

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: